15 Biggest Mid-Day Gainers For Friday - Pulmatrix (NASDAQ:PULM), Neurocrine Biosciences (NASDAQ:NBIX), Stride (NYSE:LRN)

Pulmatrix Inc PULM shares climbed 34.2 percent to $2.98 after surging 35.37 percent on Thursday.
Stonegate Mortgage Corp SGM shares jumped 28.9 percent to $7.73. Home Point Financial agreed to acquire Stonegate Mortgage for $211 million.
Lantronix Inc LTRX shares surged 17.9 percent to $1.91. Lantronix reported Q2 adjusted earnings of $0.03 per share on revenue of $11.2 million.
K12 Inc. LRN gained 16.8 percent to $19.66. K12 reported Q2 earnings of $0.30 per share on revenue of $221.1 million.
Technical Communications Corporation TCCO climbed 13.7 percent to $2.84. Technical Communications shares have declined 16.67 percent over the past 52 weeks, while the S&P 500 index has gained 21.97 percent in the same period.
Globus Maritime Ltd GLBS shares rose 10.7 percent to $10.08. Globus Maritime shares have jumped 10,022.22 percent over the past 52 weeks, while the S&P 500 index has gained 21.97 percent in the same period.
Celestica Inc CLS surged 9.5 percent to $13.97 after the company posted upbeat Q4 results.
Centrue Financial Corp CFCB rose 9.3 percent to $25.11 after Midland States Bancorp Inc MSBI reported the purchase of Centrue Financial for estimated total consideration of $26.75 per share. Centrue Financial also reported Q4 earnings of $0.33 per share.
Wynn Resorts, Limited WYNN shares climbed 8 percent to $103.12 after the company posted upbeat quarterly profit.
Daqo New Energy Corp DQ surged 7.3 percent to $24.96. Craig-Hallum initiated coverage on Daqo New Energy with a Buy rating.
VMware, Inc. VMW rose 6.2 percent to $89.42 after the company reported upbeat quarterly results and announced an additional buyback of $1.2 billion.
Datawatch Corporation DWCH shares gained 6 percent to $7.05 after climbing 17.70 percent on Thursday.
Bioverativ Inc BIVVV rose 4.6 percent to $45.76. Bioverativ will replace RH RH in the S&P MidCap 400, after the close of trading on February 2. Goldman Sachs initiated coverage on Bioverativ with a Buy rating.
Neurocrine Biosciences, Inc. NBIX gained 3.3 percent to $41.09. Oppenheimer upgraded Neurocrine Biosciences from Perform to Outperform.
Microsoft Corporation MSFT rose 2 percent to $65.54 as the company reported better-than-expected results for its fiscal second quarter on Thursday.

Market News and Data brought to you by Benzinga APIs